PWP News

News relative to Parkinson’s Disease

Can Sound Slow Parkinson’s?

The Med Guru, Published on March 23, 2009

Several small studies have suggested that music therapy can slow the progression of Parkinson’s. One of the best-known clinical trials, from Italy, found that music therapy positively affected movement, emotions and quality of life among a small group of patients.

Read more…

March 24, 2009 Posted by | Music, PD Therapies, Sound | , , | Comments Off on Can Sound Slow Parkinson’s?

Parkinson’s Disease and Multiple Sclerosis Patient Defeats His Down Hill Prognosis and Regains Mobility Without Drugs or Surgery

Yahoo News!, Wed Mar 18, 3:01 am ET

Now, because of a virtual reality device developed by an Israeli scientist called the GaitAid Virtual Walker, he’s able to get around his apartment and even outside without the aid of his walker or any other support devices.

Read more…

March 19, 2009 Posted by | PD Therapies | | Comments Off on Parkinson’s Disease and Multiple Sclerosis Patient Defeats His Down Hill Prognosis and Regains Mobility Without Drugs or Surgery

Older Adults Taught Hatha Yoga To Reduce Fear Of Falling

Medical News Today, Article Date: 10 Mar 2009 – 5:00 PDT

Indiana University researchers found promising results in an exploratory study involving yoga practice by older adults who expressed a fear of falling. After a 12-week, twice weekly hatha yoga class, taught by a professional yoga therapist, study participants reported a reduced fear of falling, increased lower body flexibility and a reduction in their leisure constraints

Read more…

March 11, 2009 Posted by | PD Therapies, Yoga | , | Comments Off on Older Adults Taught Hatha Yoga To Reduce Fear Of Falling

Long-term effects of early Parkinson’s treatments similar

Eurek Alert!, Public release date: 9-Mar-2009

“Clinicians and patients often struggle with what is the right initial approach to treating Parkinson’s disease,” said University of Rochester Medical Center neurologist Kevin Biglan, M.D., M.P.H., the lead author of the paper and a member of the Parkinson’s Study Group, an international network of researchers that oversaw the clinical trial. “This study tells us that, over the long haul, patients on the different drugs end up at roughly the same place in terms of their level of disability and quality of life.”

Read more…

March 10, 2009 Posted by | PD Therapies | | Comments Off on Long-term effects of early Parkinson’s treatments similar

Gators get their groove on during Dance for Life program

University of Florida News, Filed under Announcements, InsideUF (Campus), Top Stories on Friday, March 6, 2009.

Dance for Life, a free, therapeutic dance program for people with Parkinson’s disease, offers University of Florida students, faculty, staff and UF Movement Disorders Center (MDC) patients an opportunity to come together and dance. Dance for Life is designed to reduce motor and non-motor symptoms and enhance the well-being of Parkinson’s disease patients.

Read more…

March 8, 2009 Posted by | Dance, PD Therapies | , | Comments Off on Gators get their groove on during Dance for Life program

Teva’s Azilect Use Dramatically Increases In Second-Line Therapy For The Treatment Of Parkinson’s Disease

Medical News Today, Article Date: 05 Mar 2009 – 1:00 PST

Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that second-line patient share of MAO-B inhibitors has increased from 14.1 percent to 35.2 percent since last year’s report. Most of this increased patient share was driven by growth in the use of Teva’s Azilect which is attributed to physicians’ growing comfort with the drug and data attesting to its possible neuroprotective (disease-modifying) effects

Read more…

March 6, 2009 Posted by | PD Therapies, Pharmaceutical Industry | , | Comments Off on Teva’s Azilect Use Dramatically Increases In Second-Line Therapy For The Treatment Of Parkinson’s Disease

Teva’s Azilect Use Dramatically Increases In Second-Line Therapy For The Treatment Of Parkinson’s Disease

Medical News Today, Article Date: 05 Mar 2009 – 1:00 PST

Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that second-line patient share of MAO-B inhibitors has increased from 14.1 percent to 35.2 percent since last year’s report. Most of this increased patient share was driven by growth in the use of Teva’s Azilect which is attributed to physicians’ growing comfort with the drug and data attesting to its possible neuroprotective (disease-modifying) effects.

Read more…

March 5, 2009 Posted by | PD Therapies, Pharmaceutical Industry | , | Comments Off on Teva’s Azilect Use Dramatically Increases In Second-Line Therapy For The Treatment Of Parkinson’s Disease

A Push to Spell Out a Drug’s Risks and Benefits

The New York Times, By NATASHA SINGER, February 26, 2009

WHAT if consumers could calculate the benefits and risks of taking a prescription drug as easily as they can gauge the carbs and calories of an Oreo cookie? Inspired by the nutrition fact panels on food packaging, researchers at the Dartmouth Medical School are urging federal regulators to adopt a similar concept — numerical tables that quantify the benefits of taking a drug compared with a placebo, and that list the odds of having side effects.

Read more…

March 3, 2009 Posted by | Generic Drugs, PD Therapies, Uncategorized | , | Comments Off on A Push to Spell Out a Drug’s Risks and Benefits

Computerized brain exercises improve memory and attention

News-Medical.net / Published: Thursday, 12-Feb-2009

Study results to be published in the April 2009 issue of the Journal of the American Geriatrics Society show that computerized brain exercises can improve memory and lead to faster thinking.  Prior studies have shown that older adults perform better on cognitive tests after repeatedly practicing those tests, but this large-scale study is the first to link a commercially available software program to improvement on unaffiliated standard measures of memory and to better performance on everyday tasks.

Read more…

February 13, 2009 Posted by | Improving Memory, PD Therapies | , | Comments Off on Computerized brain exercises improve memory and attention

Australia: Parkinson’s sufferers embracing Wii

The West Australian / 11th February 2009, 9:15 WST

Parkinson’s disease sufferers who play computer games have “fun”, says an Australian professor who now wants to see whether they can also improve how sure they are on their feet. A group of seven older people with and without the degenerative condition took part in a NSW pilot project, and they were put through an almost daily regime of playing the Nintendo Wii.
The home entertainment device is controlled through arm movements, while a Wii Fit “board” was also added requiring the seated users to interact with on-screen objects using their feet.

Read more…

February 12, 2009 Posted by | PD Therapies | | Comments Off on Australia: Parkinson’s sufferers embracing Wii

Australia: Computer games help Parkinson’s sufferers

Stuff.co.nz, AAP | Wednesday, 11 February 2009

Parkinson’s disease sufferers who play computer games have “fun”, says an Australian professor who now wants to see whether they can also improve how sure they are on their feet. A group of seven older people with and without the degenerative condition took part in a NSW pilot project, and they were put through an almost daily regime of playing the Nintendo Wii.

Read more…

February 12, 2009 Posted by | PD Therapies | | Comments Off on Australia: Computer games help Parkinson’s sufferers

What causes motor complications of Parkinson’s treatment?

PhysOrg.com

January 29th, 2009 in Medicine & Health / Research

The Graybiel Lab caused Parkinson’s disease in rats by depleting dopamine in the right side of the striatum, the brain region that drives the abnormal movements in the disease, leaving the left side as the control.

Read more…

February 3, 2009 Posted by | Dyskinesia, L-dopa, PD Therapies, Therapy Side Effects | | Comments Off on What causes motor complications of Parkinson’s treatment?